Ocugen

Malvern, United States

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

May 2026

Post-IPO Debt

Top Investors

Janus Henderson InvestorsAvenue Capital GroupRTW InvestmentsROTH Capital PartnersAbdi Ibrahim Pharmaceuticals

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Ocugen's investors?

Ocugen's investors include Janus Henderson Investors, Avenue Capital Group, RTW Investments, ROTH Capital Partners, Abdi Ibrahim Pharmaceuticals.

Where is Ocugen headquartered?

Ocugen is headquartered in Malvern, United States.

What does Ocugen do?

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

What stage is Ocugen at?

Ocugen is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 4, 2026.

MLA

"Ocugen — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/ocugen. Accessed June 3, 2026.

APA

VCBacked. (2026). Ocugen — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ocugen

Wikipedia (cite web)

{{cite web |title=Ocugen — Funding & Investors |url=https://www.vcbacked.co/company/ocugen |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 4, 2026.